Search Orphan Drug Designations and Approvals
-
| Generic Name: | an anti-CD228 monoclonal antibody conjugated with MMAE payload |
|---|---|
| Date Designated: | 03/24/2025 |
| Orphan Designation: | treatment of metastatic (stage IV) lung squamous cell carcinoma |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Shandong Boan Biotechnology Co., Ltd. No.39 Keji Avenue, Yantai Hi-Tech Zone Yantai, Shandong Province 264003 China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







